CHAPEL HILL, N.C. and CHARLOTTESVILLE, Va.–(Business Wire)–Cempra Pharmaceuticals, Inc., and Biovista, Inc., announced today that they have entered into a research agreement to systematically identify and profile adverse event associations for members of the macrolide drug class. The data generated will be used to better understand the unique benefit/risk characteristics of this important group of … Read More
News
Nano2life 2008: Knowledge Discovery using literature mining
Knowledge Discovery using literature mining Heraklion, Crete Dr. Andreas Persidis, Biovista Date: Friday, 27 June 2008 Section: Nano2Life Scientific Meetings
Biovista initiates its Macular Degeneration and CNS drug repositioning programs.
Charlottesville, VA and Athens, Greece. Biovista began work today on two internal programs aimed to reposition marketed drugs or drugs in Phase II/III in Macular Degeneration and CNS. Biovista has already identified a number of candidates with the requisite biological plausibility that are also unencumbered by prior patent filings or prior art. The Company is … Read More
Biovista contributes to clinical trials research on Wilms tumor and breast cancer.
Athens, Greece and Charlottesville, VA. Biovista has joined the European ACGT consortium developing advanced semantic technologies in support of post genomic clinical trials in cancer. The aim of this work is to create an IT grid-based infrastructure that will support clinicians and bio-researchers in clinical trial design and research in two cancer modalities: Wilms tumor … Read More
Biovista Nutrition wins Great Gear of the Year award
Charlottesville, VA Biovista announced today that its consumer oriented Biovista Nutrition site was awarded the Great Gear of the Year Award by ShapeYou.com for the year 2007 (see http://www.shapeyou.com/old/awards/web_software.html). “We are very pleased to have received this award that recognizes excellence in providing useful and simple to use tools to a wide range of people … Read More